Six major chronic diseases – cancer, heart disease, lung disease, diabetes, depression and rheumatoid arthritis – account for nearly two-thirds of the total healthcare costs in most countries.
We aim to satisfy a minimum of three criteria: high prospects for meaningful patient benefits, significant potential for healthcare cost savings and a high likelihood that clinicians will become more efficient in disease management.
Utilize our established best-practices and knowledge to form the foundations for new and successful technology-driven business, providing seed funding and other support.
Through our internal and global network, our portfolio companies have access to the clinical and market expertise and capital necessary to drive growth and deliver value to patients, clinicians, payers, employees and shareholders.
